Toucan Capital is a venture capital investment firm specializing in early-stage life science & regenerative medicine investments. The firm was founded in 1998 and is based in Bethesda, Maryland.
Toucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is an active venture capital funds in seed and early-stage life science. Toucan has also been an early investor in nanotechnology.
Toucan Capital Fund III is a venture capital fund focused on regenerative medicine and immune therapy investments.